Clinical trial
GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets
NCT00499824 · International Diabetes Institute, Australia, Other · Completed
Key facts
| NCT number | NCT00499824 |
|---|---|
| Title | GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets |
| Official title | GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets |
| Acronym | GIANT |
| Lead sponsor | International Diabetes Institute, Australia, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Behavioral |
| Interventions | Education of general practitioners on the IDF-WPR guidelines |
| Enrollment | 386 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Jul 11, 2007 |
| Last update posted | May 4, 2010 |
| Countries | China, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: